Macrophage Polarization during MRONJ Development in Mice

• Published in: Journal of dental research Vol. 103; no. 9; pp. 899 - 907
• Main Authors: Soundia, A., Elzakra, N., Hadaya, D., Gkouveris, I., Bezouglaia, O., Dry, S., Aghaloo, T., Tetradis, S.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.08.2024; SAGE PUBLICATIONS, INC
• Subjects: Bone remodeling; Collagenase 3; Computed tomography; Developmental stages; Gum disease; Macrophages; Necrosis; Osteonecrosis; Periodontal diseases; Phenotypes; Polarization; Rosiglitazone; Zoledronic acid; osteonecrosis; periodontal disease(s)/periodontitis; immunity; bone biology; inflammation; periodontal tissues/periodontium
• ISSN: 0022-0345; 1544-0591; 1544-0591
• DOI: 10.1177/00220345241258990

Macrophages are important regulators of bone remodeling, and M1 polarization is observed in the setting of medication-related osteonecrosis of the jaws (MRONJ). Here, we characterize the phenotype of macrophages during early stages of MRONJ development in zoledronate (ZA)–treated mice with periodontal disease and explore the role of rosiglitazone, a drug that has been reported to lower the M1/M2 macrophage ratio, in MRONJ burden. Mice received ZA, and experimental periodontal disease (EPD) was induced around their second left maxillary molar. The mice were euthanized 1, 2, or 4 wk later. Micro–computed tomography and histologic and immunohistochemical analyses were carried out. In a separate experiment, mice were treated with ZA in the absence or presence of rosiglitazone, EPD was induced for 5 wk, and the MRONJ burden was assessed. An M1 predilection was noted in ZA versus vehicle (Veh) mice at 1, 2, or 4 wk after ligature placement. M1 cells were found to be positive for MMP-13, and their presence coincided with disruption of the surrounding collagen network in ZA mice. Rosiglitazone caused a reversal in the M1/M2 polarization in Veh and ZA mice. Rosiglitazone did not cause significant radiographic changes 5 wk after EPD in Veh or ZA animals. Importantly, percentage osteonecrosis and bone exposure were decreased in the rosiglitazone-treated versus nontreated ZA sites 5 wk after EPD. Our data point to an important role of M1 macrophage polarization with an overexpression of MMP-13 in the early phases of MRONJ development and provide insight into the use of interventional approaches promoting an M2 phenotype as a preventative means to alleviate MRONJ burden.